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ABSTRACT. To encourage cell adhesion on biomaterial surfaces in a more facile, safe, and low-
cost fashion, we have demonstrated a non-covalent approach to spatially conjugate β-
cyclodextrin (β-CD) modified peptide sequences onto self-assembled adamantane-terminated 
polystyrene-b-poly(ethylene oxide) (PS-PEO-Ada) films through inclusion complexing 
interactions between β-CDs and adamantane.  By simply blending various ratios of unmodified 
PS-PEO with a newly synthesised PS-PEO-Ada, we produced PS polymer films that displayed 
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well-organized adamantine-decorated cylindrical PEO domains with varying average 
interdomain spacings ranging from 29 to 47 nm.  The presence of the adamantane moiety at the 
terminal end of the PEO chain permitted rapid, and importantly, oriented attachment of β-CD 
functionalized peptides onto these surfaces. This one-step process not only converted these 
proven non-adherent PS-PEO surfaces into adherent surfaces, but also permitted precisely 
controlled presentation and surface distribution of the conjugated peptides. The utility of these 
surfaces as cell culture substrates was confirmed with human mesenchymal stem cells (hMSCs).  
We observed that with increasing PS-PEO-Ada content in the PEO cylindrical domains, these 
novel polymer films displayed improved cell attachment and spreading, with notable differences 
in hMSC morphology.  We further confirmed that this novel PS-PEO-Ada surface provides a 
flexible platform for facile conjugation of mixtures of β-CDs functionalized with different 
peptides, specifically RGD and IKVAV peptides. The cell adhesion and spreading assays on 
these surfaces indicated that the morphologies of hMSCs can be easily manipulated, while no 
significant changes in cell attachment were observed. The ‘lock-and-key’ peptide conjugation 
technique presented in this work is applicable to any substrate that incorporates a moiety capable 
of forming inclusion complexes with α-, β- and γ-CDs, providing a facile and flexible method by 
which to construct peptide-conjugated biomaterial substrates for a multitude of applications in 
fields ranging from cell bioprocessing, regenerative medicine to cell-based assays. 
 
INTRODUCTION 
The adhesion of cells to biomaterial surfaces is an important prerequisite for the successful 
integration of implants in vivo or the colonization of scaffolds intended for tissue engineering 
applications. To encourage cell adhesion, conventional man-made biomaterial surfaces typically 
 3 
require pre-treatment, prior to them being further modified with either full-length extracellular 
matrix (ECM) proteins or conjugated with desired peptide sequences that can replicate sequences 
(in terms of number and type) available in full-length (ECM) proteins. Thus far, most of these 
pre-treatment protocols have involved a variety of chemical schemes, such as amination, 
esterification, click chemistry, and other multi-step reactions, depending on the functionalities 
presented on the biomaterial surfaces.1-4 These reactions, however, tend to be carried out in the 
presence of toxic chemicals, under precisely controlled conditions (e.g. pH, temperature), and via 
tedious and time-consuming procedures, with limited options for the conjugation of multiple 
different peptide sequences. To address these drawbacks, we have developed a facile, one-step, 
water-based, low cost strategy to conjugate diverse peptides sequences onto biomaterial surfaces 
using cyclodextrins. 
    Cyclodextrins (CDs) are toroidally shaped polysaccharides with hydrophobic inner cavities. 
This unique molecular structure endows CDs with capacities to either partially or entirely 
accommodate suitably sized lipophilic guest moieties (e.g. aromatic compounds, ferrocene, 
cholesterol, and adamantane groups (in the case of β-CD)), forming a diverse set of host-guest 
inclusion complexes through facile hydrophobic and van der Waals interactions.5-8 Taking 
advantage of these highly defined CD-guest interactions, CDs have been widely utilized in 
separation technologies, food processing, and pharmaceutical formulations.9,10 Nevertheless, thus 
far there have been no reports of the utilization of these facile non-covalent interactions to 
conjugate peptide sequences onto biomaterial surfaces for cell adhesion. 
    Previously, it has been demonstrated by us that through the rapid self-assembly of asymmetric 
polystyrene-b-poly(ethylene oxide) (PS-PEO) on a hydrophobic substrate, it is possible to 
produce a thin film consisting of separated, vertically oriented cylinders constructed from a 
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number of PEO chains in a matrix of PS.11,12 Moreover, the lateral spacing of these cylindrical 
PEO domain size can be effectively controlled by the molecular weight of PS-PEO, additional 
annealing treatment, and blending with PS homopolymer.11-13 Particularly, our recent study 
revealed that the modification of PEO chain end with functional motif such as maleimide does 
not alter the nano-presentation of surface functionalities in terms of their distribution.13 This 
finding opened a broad avenue for generating versatile PS-PEO substrates with well-controlled 
nano-presentation of surface functionalities. More recently, the control of nanoscale features of 
biomaterial substrates has been proven, by us and others, to be a powerful tool to regulate stem 
cell behaviours, such as adhesion, spreading, differentiation and apoptosis, by the surface nano-
presentation of cell adhesive molecules.14-18 
    Herein, we present the synthesis and characterisation of adamantyl moiety functionalized PS-
PEO (PS-PEO-Ada). We show that upon rapid self-assembly of PS-PEO-Ada, a polymer film 
bearing adamantyl motifs on the surfaces of cylindrical PEO nanodomains was generated. 
Taking advantage of the specific interaction between admantyl groups and β-CD, we confirm 
that β-CD modified peptide sequences (RGD and IKVAV) can be rapidly, non-covalently 
conjugated onto the PS-PEO-Ada films through a simple one-step incubation process (Scheme 
1). Considering the unique surface nanostructures of the self-assembled PS-PEO-Ada films, we 
proposed that β-CD modified peptide conjugated PS-PEO-Ada films may be a viable culture 
platform for stem cells, and be capable of modulating their behaviors. In order to test this 
suggestion, and owing to their potential for tissue engineering and regenerative medicine 
applications, human mesenchymal stem cells (hMSCs) were cultured on the PS-PEO-Ada 
substrates.19 The surface nano-presentation of these non-covalently conjugated peptide sequences 
were indeed shown to modulate the attachment and morphology of hMSCs in our current study, 
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proving the utility of this methodology for a multitude of cell culture and regenerative medicine 
applications. 
    Compared with more conventional methods of functionalizing biomaterial substrates with 
peptides to encourage cell adhesion and expansion, these novel surfaces have a number of 
advantages: 1) the peptide conjugation process was performed in neutral water, at room 
temperature, and in the absence of any additional chemicals, therefore it is a facile, safe and low 
cost protocol to bind and present cell adhesion molecules on biomaterial surfaces; 2) depending 
on the inter-domain spacing of PEO nanodomains, the surface distribution of the desired peptide 
sequence can be precisely tuned; 3) owing to the defined interaction between adamantyl groups 
and β-CD, multiple different CD modified peptide sequences can be conjugated onto the 
substrates, without having to consider the differences in reactivity and selectivity of the peptide 
sequences, as is the case in many conventional chemical reactions used in biomaterial 
functionalization. Analogously, as cyclodextrins, including α-, β- and γ-CD, form inclusion 
complexes with a diverse range of hydrophobic moieties (e.g. aromatic compounds, ferrocene, 
cholesterol, adamantane, poly(propylene oxide), etc.), it may be expected that any CD modified 
peptides can be conjugated onto a surface bearing the corresponding ‘best fit’ hydrophobic 
moieties for a given CD moiety by following the same protocol as developed here. Our protocol 
thus provides a very flexible methodology by which to construct biomaterial platforms with 
controllable nano-presentation of different peptide sequences. 
 
MATERIALS AND METHODS  
Materials  
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PS-PEO block copolymer, with a PS block molecular weight of 51 kDa and a PEO block of 11.5 
kDa, was purchased from Polymer Source Pty. Ltd. (Montreal, PQ, Canada).  β-CD was 
purchased from Sigma-Aldrich and purified by recrystallization in MilliQ water prior to use. 
CGRGDS and CGIKVAV peptides were supplied by Peptide 2.0 Inc. (Chantilly, VA, USA) and 
used as received. Sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate (Sulfo-
SMCC) was purchased from ProteoChem. 1-Adamantyl isocyanate, Di-n-butyltin dilaurate 
(DBTL), anhydrous toluene and N,N-dimethylformamide (DMF), and all chemicals for synthesis 
of amine mono-substituted CD were purchased from Sigma-Aldrich and used as supplied. All 
materials for hMSCs culture, staining and imaging were purchased from Sigma unless otherwise 
stated. 
Synthesis of PS-PEO-Ada 
Dry PS-PEO (625 mg) and 1-adamantyl isocyanate (90 mg) were dissolved in 10 mL of 
anhydrous DMF with vigorous stirring in nitrogen atmosphere, followed by the addition of 
DBTL (2.2 mg). The reaction temperature was elevated to 80 oC and left to react for 24 h. The 
reaction mixture was dialyzed against chloroform at room temperature for 3 days. After 
removing solvent by rotor-evaporation, a white PS-PEO-Ada polymer solid was collected and 
further dried under vacuum overnight. 
Synthesis of β-CD modified peptides  
Amine mono-substituted β-CD (CD-NH2) was firstly synthesized as described previously.20 To 
synthesize β-CD modified peptides, CD-NH2 (3.6 mg, 3.2 µmol) and sulfo-SMCC (1.1 mg, 3.2 
µmol) was dissolved in 2.0 mL of phosphate buffered saline (PBS) aqueous solution with gentle 
stirring. After the reaction proceeded for 1 h, 6.4 µmol of peptide (CGRGDS and CGIKVAV ) 
was added into the reaction mixture, followed by another 4 h of reaction.  β-CD modified peptide 
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solutions (CD-RGD and CD-IKVAV) were obtained and further diluted with 10 mL of PBS 
solution. 
Preparation of peptide-conjugated polymer surfaces  
Glass slides (13 mm in diameter) were exposed to UV/ozone for 20 min to remove any organics. 
The slides were then rendered hydrophobic by boiling in benzyl alcohol for 4 h, and further 
rinsed thoroughly in isopropanol and dried under a stream of nitrogen. Polymer films were 
generated by spin casting polymer solutions in toluene (2% wt/vol) onto the treated glass slides 
at 2000 rpm. The polymer coated glass slides were then transferred to a 24-well plate with 0.5 
mL of diluted β-CD modified peptide solution (0.32 mM) in each well and left to incubate for 8 
h at room temperature. Thereafter, the surfaces were thoroughly rinsed in MilliQ water to 
remove any un-reacted chemicals and excess amounts of peptides. 
Material characterization  
1H NMR and X-ray photoelectron spectroscopy (XPS) spectra: 1H NMR spectra of the polymer 
samples were acquired at 298 K in deutorochloroform (CDCl3) on a Bruker Avance 750 
spectrometer. XPS analysis was performed using an ESCALAB 250 from Thermo VG Scientific. 
Monochromatic Al Kalpha X-rays were used (15 kV, 150 W, ~500 µm spot diameter). The 
transmission function of the analyzer was calibrated using a standard copper sample. Spectra 
were measured using a pass energy of 80 eV for survey spectra. 
Quartz crystal microbalance with dissipation monitoring (QCM-D): A Q-Sense QCM-D E4 was 
used to in-situ monitor the conjugation of β-CD modified peptides onto PS-PEO-Ada surfaces. 
Briefly, QCM crystal was pre-coated with a PS-PEO-Ada layer on a gold substrate following the 
procedures described above. The crystals were then thoroughly rinsed in MilliQ water and dried 
under a stream of nitrogen. Thereafter, a PS-PEO-Ada film was mounted onto the treated crystals 
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by spin coating PS-PEO-Ada solution in toluene (20% w/v) at 2000 rpm.  After a polymer coated 
crystal and a bare treated crystal were assembled into the QCM-D instrument, PBS solution was 
continuously injected into the QCM chamber at a rate of 50 µL/min, and the system was 
equilibrated for 30 min. After confirming a stable baseline, the PBS solution was then replaced 
with a CD modified CGRGD solution in PBS. Once the frequency and dissipation curves again 
reached their new baseline, the injection solution was replaced with a fresh PBS solution to rinse 
away any freely absorbed molecules. The QCM-D data was analyzed using QTools software. 
Water contact angle:  The water contact angles of the substrates were determined by a sessile 
drop method at 25 oC using a contact angle goniometer (CAM 100, KSV Instruments Ltd.). A 5 
µL droplet of water was placed on the substrates. All samples were prepared as triplicates and 
the results shown are the mean value with a single standard deviation. 
Atomic force microscopy (AFM): Imaging of the self-organized polymer films on glass slides 
was carried out on a Multimode Nanoscope-IIIa Scanning Probe Microscope (Digital Instrument 
Co., Ltd. U.S.A.) equipped with a NT-MDT silicon cantilever (NSCII, radius < 10nm, resonance 
frequency = 300 kHz, nominal spring constant = 42 N/m, vertical resolution < 0.03 nm, lateral 
resolution < 2 nm) by using the AC mode at room temperature. The AFM is mounted on an anti-
vibrational table (Herzan) and operated within an acoustic isolation enclosure (TMC, USA). 
hMSC culture, staining and imaging  
Cell culture:  Human bone-marrow MSC (hMSC, supplied by Dr Gary Brook at the Mater 
Medical Research Institute, Brisbane, Australia) were cultured in low-glucose DMEM 
supplemented with 100 U/mL penicillin, 100 ug/mL streptomycin (DMEM/ps) and 10% batch-
tested foetal bovine serum (FBS) at 37 oC in 5% CO2 in an atmosphere with 95% humidity. 
Upon reaching 70% confluence, hMSCs were passaged and reseeded at an approximate density 
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of 2000 cells/cm2.  Prior to seeding the cells onto PS-PEO-Ada–peptide surfaces in serum-free 
media (DMEM/ps and 1% ITS+; Sigma), MSCs were detached with TrypLE Select (Invitrogen), 
resuspended in 1% bovine serum albumin (BSA) in PBS then washed thoroughly. 
Cell attachment assays:  Prior to use in cell culture experiments, PS-PEO-Ada–peptide surfaces 
were sterilized by immersing them in ethanol sol (75%) for 10 min, followed by thoroughly 
rinsing with PBS.  hMSCs were seeded onto PS-PEO-Ada–peptide surfaces at a density of 3000 
cells/cm2 in serum-free media and allowed to attach for 2 hours. Attachment levels were 
determined by Crystal Violet assay. Briefly, surfaces were washed twice in PBS to remove 
unattached or weakly attached cells, and the remaining cells then fixed in 4% paraformaldehyde 
(Sigma-Aldrich, Sydney, Australia) for 20 minutes and stained with 0.1% (w/v) Crystal Violet 
(Sigma-Aldrich) in 200 mM 2-(Nmorpholine) ethanesulfonic acid (Sigma-Aldrich), pH 6.0 for 
10 minutes. Cells were washed five times in MilliQ water to remove excess Crystal Violet before 
the addition of 100 ml of 10% glacial acetic acid. Absorbance was read at 590 nm using a 
Spectramax M5 Fluorometer (Molecular Devices). 
Analysis of cell morphology:  hMSCs were cultured on the peptide conjugated PS-PEO-Ada 
surfaces at a density of 3,000 cells/cm2 in serum-free media for a period of 24 hours, washed in 
PBS and fixed for 10 minutes in 4% paraformaldehyde. The cells were then permeabilized in 
0.1% Triton X-100 in PBS for 5 minutes, and stained with Hoechst and FITC-phalloidin. 
Samples were rinsed thoroughly in PBS and mounted onto glass slides in Vectashield containing 
DAPI (Vector Laboratories). The cells were imaged using an Olympus BX61 fluorescent 
microscope. The resulting images were analysed using ImageJ 1.42 software (NIH, Bethesda, 
MD). 
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RESULTS AND DISCUSSION  
Polymer surfaces with tunable surface architectures. PS-PEO-Ada was synthesized by 
reacting the hydroxyl pendant group on the PEO block of the PS-PEO polymer and adamantyl 
isocyanate in the presence of DBTL. The synthesis of PS-PEO-Ada was confirmed by 1H NMR 
analysis (Figure 1a). Compared with unmodified PS-PEO, PS-PEO-Ada demonstrated new shifts 
situated at 1.69, 2.01 and 2.09 ppm, corresponding to the H1 chemical shifts of adamantyl groups 
on the polymer chain end. 
Figure 1. here 
Upon rapid self-assembly, PS-PEO can self-organize into a thin film with well-defined 
cylindrical PEO domains uniformly distributed into PS matrix (Figure 2a). As determined by 
AFM observation, the average inter-domain spacing the PEO domains was 29.0 nm. The PEO 
domain diameter was 16.4±1.4 nm, respectively (Figure 2a and 2e). To highlight the use of the 
polymer films with well controlled surface nano-presentation of peptide sequences, the polymer 
surfaces bearing different densities of adamantyl groups in PEO domains, and thus controlled 
numbers of non-covalently conjugated β-CD modified peptide sequences in each nanodomain, 
were generated by co-self-assembly of PS-PEO with different amounts of PS-PEO-Ada. 
Interestingly, when 25 wt% of PS-PEO-Ada was mixed with PS-PEO, a polymer film with well-
organized cylindrical PEO domains of dia. 16.8±1.5 nm was achieved (Figure 2b). Following a 
similar blending technique, further increases in the amount of PS-PEO-Ada up to 50 wt% and 75 
wt% resulted in the formation of polymer films with significantly increased average inter domain 
spacings, being 39 and 47 nm, respectively, but only slight increases in domain diameters 
(17.2±2.0 and 18.9±2.2 nm). Moreover, all the resultant blended polymer films presented well-
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defined cylindrical PEO domains (Figure 2c-2e). Further AFM analysis confirmed that the self-
assembly of pure (100%) PS-PEO-Ada resulted in a thin film with irregular surface 
nanostructures, differing substantially from that of the PS-PEO and the PS-PEO-Ada blended 
systems (Figure 2f). However, if a line plot is made of this surface, whilst the surface lacks 
clearly defined separation between domains in some regions, the majority of structure are 
separated by an inter-domain spacing of between 35 to 105 nm, and the nanodomains have cross 
sections ranging from 21 to 55 nm.  
Figure 2 here 
The β-CD modified RGD and IKVAV were synthesized by linking amine-monosubstituted β-CD 
and cysteine terminated RGD and IKVAV using sulfo-SMCC as a coupling agent. Taking 
advantage of the formation of an inclusion complex between adamantane with β-CD, these β-CD 
modified peptides can be easily conjugated onto PS-PEO-Ada surfaces through facile non-
covalent interactions. To evidence this assumption, after the self-assembled PS-PEO-Ada film 
was conjugated with β-CD modified peptide sequences, and then thoroughly rinsed in MilliQ 
water to remove any un-reacted products, the resultant surface was subjected to XPS analysis 
(Figure 1b). In comparison to the bare PS-PEO-Ada films, both CD-RGD and CD-IKVAV 
conjugated PS-PEO-Ada surfaces exhibited a sharp N1s peak at 398 eV, proving the successful 
conjugation of peptide sequences on the polymer surfaces. However, no feature N1s peak was 
observed on PS-PEO surface that was incubated with CD-RGD for 18 h followed by a thorough 
rinse with MilliQ water. This fact proved that the conjugation of CD modified peptides on PS-
PEO-Ada surface is through the selective interactions between CD and adamantane group rather 
than nonspecific physisorption interactions. 
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To further characterise this peptide conjugation process, the time course of Δf upon exposure of 
the polymer coated QCM crystal to a CD-RGD solution in PBS (0.3 mM) was recorded at 25 oC 
(Figure 3a). In the case of 75% PS-PEO-Ada coated QCM crystal, after injection of the CD-
RGD solution at 50 uL/min, there was a gradual decrease in the resonant frequency, 
accompanied by a slow shift in the dissipation, evidencing continuous adsorption of the CD-
peptide onto the PS-PEO-Ada surfaces. After 340 min, Δf reached equilibrium, indicating a 
saturated surface of immobilized CD-RGD. Thereafter, rinsing the peptide immobilized surfaces 
with PBS had little effect on Δf, which suggests an irreversibly bound CD-RGD. According to 
the equilibrium values of Δf obtained after rinsing with PBS, the surface binding CD-RGD 
amount was calculated as 19.5 ng/cm2 through a Sauerbrey relation.21 In addition, the QCM data 
showed that the achievement of saturation of binding of CD-RGD on the 75% PS-PEO-Ada 
surface required a significant amount of time (~ 340 minutes). This is due to the fact that on this 
particular polymer surface, the adamantane motifs decorate not only to top surface or outer 
perimeter of the PEO nanodomains, but also all of the inner walls of each cylindrical PEO 
nanodomains that penetrate into the depth of the film. As discussed in more detail below, this 
surface thus has a significant binding capacity for any conjugate, supporting the timeframe of 
surface saturation. Furthermore, the actual rate of binding of modified CDs to the surface is 
relatively constant, as shown by the consistency in the d(Δf )/dt during the conjugation event, 
corresponding to ~55 pg/cm2/min, a reasonable rate considering that this process will be 
diffusion-dominated.   
The outer perimeter of each PEO cylinder of diameter 19 nm is composed of approximately 27 
PEO chains (based on a hydrodynamic radius of each PEO chain (11000 g/mol) of  ~ 2.2 nm 
(calculated according to the method described in [22])). The functionalised β-CD-RGD is 
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estimated to be of a similar size to the PEO (β-CD alone is 1.66 nm), meaning that at maximum 
packing on the outer rim of one cylinder composed of 75% PS-PEO-Ada, we may obtain ~27 
conjugated CD-RGD molecules. Further, each PEO cylinder is of a height of ~ 40 nm 
(determined from film thickness measurements using ellipsometry and X-ray reflectometry),23 
meaning that in addition to the top most surface-exposed layer of the PEO chains within these 
cylinders, there are approximately 18 additional layers of PEO chains protruding into the 
cylinder over its length. Therefore, in each cylinder composed of 75% PS-PEO-Ada, there are a 
total of ~364 PEO-Ada binding sites for CD-RGD. At an inter-cylinder spacing of 47 nm, and a 
total molecular weight of ~ 1964 g/mol for the CD-RGD molecule, we would thus estimate that 
at 100% conjugation, we should measure a mass of 59.2 ng/cm2 on our 75% PS-PEO-Ada 
surface. However, due to steric hindrance and chain effects, we would expect to achieve a lower 
level of conjugation than 100%. Our measured mass of 19.5 ng/cm2 actually equates to a 
conjugation level of CD-RGD on the 75 % PS-PEO-Ada surfaces of 33%, or ~ 7 CD-RGD 
molecules (on average) conjugated on the top most surface-exposed layer of each PEO cylinder, 
that would be available for cell binding. Further QCM tests indicated that 25% , 50%, and 100% 
PS-PEO-Ada substrates exhibited the similar CD-RGD binding kinetics to that of 75% PS-PEO-
Ada substrate. The measured mass on 25%, 50%, and 100% PS-PEO-Ada substrates is 8.8, 14.9, 
and 25.2 ng/cm2, respectively. Thus the corresponding conjugation levels of the CD-RGD on 
those surfaces are 44%, 38%, and 32%, respectively. We thus estimate that there would be ~ 4 
CD-RGDs per 17.2 nm (dia.) cylinder on the 50% PS-PEO-Ada surface, and ~ 2 CD-RGDs per 
16.8 nm (dia.) cylinder on the 25% PS-PEO-Ada surface. In contrast, bare PS-PEO surface 
showed little CD-RGD binding, further evidencing that bind of CD-RGD on the polymer 
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surfaces is through the specific CD-adamantane interactions rather than the non-specific physical 
absorptions. 
From the water contact angle measurement results shown in Figure 3b, the water contact angle of 
(75%) PSPEO-Ada surface was significantly decreased from 83.9±1.2 o to 32.9±2.5 o after CD-
RGD conjugation (Figure 3b). This significant change in surface wettability further confirmed 
the conjugation of our CD-RGD to the polymer surfaces. 
Figure 3 here 
Nanoscale spatial distributions of RGD peptide regulated hMSC adhesion. Encouraged by 
the recent reports of surface-regulated stem cell behaviours, we investigated the effect of the CD-
RGD modified PS-PEO-Ada surface on hMSC attachment and morphology. After 2 h of culture 
on these surfaces, hMSC attachment was quantified by crystal violet staining. As shown in 
Figure 4, rather low cell adhesion was evident on PS-PEO alone, on PS-PEO-Ada alone, or on 
PS-PEO surfaces that had been incubated with CD-RGD (prior to the addition of cells). In 
contrast, the CD-RGD conjugated polymer surface containing 25 wt% of PS-PEO-Ada exhibited 
significantly enhanced hMSC attachment. This result suggests that hMSC adhesion is being 
mediated specifically by the surface conjugated CD-RGD, rather than by the physiosorption of 
the CD-RGD onto the PS-PEO polymer surfaces. The CD-RGD conjugated surfaces with 50 
wt% of PS-PEO-Ada content demonstrated a further increase in hMSC adhesion, to a similar 
level to that achieved on tissue culture plastic (TCP, positive control). However, no further 
improvement in cell adhesion was observed on the polymer surfaces with further increased PS-
PEO-Ada content (up to 75 wt%), nor at 100 wt% (pure PS-PEO-Ada surfaces). This trend in 
hMSC attachment being dependent on the PS-PEO-Ada content in the substrate is related to the 
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density of surface binding RGD motifs. At 50 wt% of PS-PEO-Ada component, the number of 
adamantane moieties presented on the self-assembled polymer surfaces obviously reached a level 
at which the number of surface-conjugated CD-RGDs was sufficient enough for maximal cell 
adhesion and thus any further increase in the number of binding sites for CD-RGD through 
additional adamantane moieties within the PEO cylinders did not lead to a continuous 
improvement on the cell adhesion. This is likely due to the increasing levels of ligand 
redundancy (in terms of available integrin-ligand binding sites) within each of the PEO cylinders 
as the amount of PS-PEO-Ada in the substrate increases.  
Figure 4 here 
After hMSCs were seeded on the surfaces with different contents of PS-PEO-Ada (0-100 wt%) 
for 24 h, the morphologies of the resulting spread cells were investigated using Confocal 
Fluorescence Microscopy. The very few cells poorly adhered to the PS-PEO surfaces exhibited 
non-polarized and rounded morphologies and had a poorly organized actin cytoskeleton with no 
stress fibres (Figure 5a). No obvious changes in cell morphology were observed post the 
incubation of this surface with solubilised CD-RGD, suggesting, as expected, that no RGD was 
immobilized on PS-PEO surface (Figure 5b). However, with increased content of PS-PEO-Ada 
in the PS-PEO polymer films, and post incubation of these surfaces with solubilised CD-RGD, 
an increase in the proportion of hMSCs with spread morphologies was observed (Figure 5c-e). In 
particular, the cells on CD-RGD conjugated 100% PS-PEO-Ada surface demonstrated highly 
polarized, well spread morphologies, with a well-organised actin cytoskeleton and multiple stress 
fibres (Figure 5f). In contrast, the cells on the 100% PS-PEO-Ada alone surface (without the CD-
RGD incubation step) displayed rounded shapes and significantly decreased spreading and had a 
poorly organized actin cytoskeleton (Figure 5g). Using ImageJ image analysis, the average cell 
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spread areas of the attached hMSCs was calculated and plotted as function of the content of PS-
PEO-Ada in the PS-PEO polymer substrates (Figure 5h). As expected, hMSCs on the non-RGD-
conjugated PS-PEO-Ada exhibited a round morphology with a slightly increased spread area 
(1400 µm2) compared to the bare PS-PEO surface (980 µm2), but with a much lower spread area 
than that of CD-RGD conjugated 100% PS-PEO-Ada surfaces (3530 µm2). With an increasing 
content of PS-PEO-Ada in the substrates, and thus increasing number density of RGD-modified 
CD within each nanodomain (of near equivalent diameters (~17 – 19 nm)), the average spread 
area of hMSCs increased from 1488 µm2 on the 25% CD-RGD conjugated PS-PEO-Ada surface 
(interdomain spacing of 29nm) to 2718 µm2 on 75% CD-RGD conjugated PS-PEO-Ada surface 
(interdomain spacing of 47 nm).  Given our previous insights into the effects of nano-scale 
presentation of covalently-bound adhesion motifs on hMSC differentiation,16 these significant 
changes in morphology and spread area of hMSCs suggests that the differentiation of hMSCs 
may be also manipulated on these non-covalently conjugated RGD substrates, emphasising the 
potential of these surfaces for stem cell selection and fate control. 
However, intriguingly, the increasing inter-domain spacings of 30 to 47 nm apparent with 
increasing amounts of PS-PEO-Ada from 25 to 75%, we may have expected to see reductions in 
mesenchymal stem cell spread area of approximately 24%, as we have previously reported when 
increasing the lateral spacing of similarly sized PEO nanodomains (~ 12 nm) presenting 
covalently bound RGD motifs.16 Similar results were also achieved in Spatz's group with 
MC3T3 osteoblasts, where they revealed that the increase of inter-spacing of cyclic RGDfK 
peptides patches caused a significant decrease of cell spread area.17 Even though 100% PS-PEO-
Ada surface has no well-defined nanopatterns, the existence of 35~105 nm inner-domain 
spacings between the separated domains also is expected to lead to a significant decrease in 
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hMSC cell area. However, we in fact observed just the opposite in this current work, with a 
significant increase in spread area.  
Due to the inherent tunability of these PS-PEO/PS-PEO-Ada surfaces, in terms of the number of 
adhesion motifs able to be conjugated within one nanodomain, we are now able to provide new 
insight into the manner by which adhesion motifs displayed to hMSCs affect their adhesion and 
morphology. This data shows that increasing the number of the cell adhesive ligands within the 
nano-sized domains can affect greater control over cell adhesion and cell spread area than any 
increases in inter-domain spacing, at least over the range of ~30 – 50 nm. However, the 
limitation in size of the nanodomains under all conditions (in the range of that of a single integrin 
24) means that this effect cannot be attributed to an enhanced ability of the substrates containing 
PS-PEO-Ada to support integrin clustering (which is a prerequisite for focal adhesion formation 
and subsequent stress fibre formation) due simply to spatial orientation, in the manner described 
by Maheshwari et al 25 who used star-PEGs to present differing cluster sizes of RGD peptides.  
This outcome is instead believed to be due to increased ligand redundancy. As the number of 
CD-RGDs within a nanodomain increases, these substrates offer increased ligand redundancy for 
integrin-ligand binding.  Rossier et al. have recently shown that within focal adhesions, whilst 
our previous understanding may have suggested that integrins are stably adherent, they in fact 
undergo repeated anchoring cycles, constantly switching between active and inactive states.26 
The increased ligand number in each nanodomain thus creates a higher probability of longer time 
localized integrin-ligand binding events, which will result in increased focal adhesion stability 
and maturation. This will result in greater force transmission, maturation of the actin 
cytoskeleton and increased spreading. 
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Effects of peptide sequence type on the hMSC adhesion.  As these CD modified peptides 
enable conjugation to our adamantane-containing surfaces through non-covalent inclusion 
complex interactions, it is now clearly possible to quantitatively conjugate different types of (and 
ratios thereof) CD modified peptides onto those polymer surfaces. We thus next explored the 
immobilization of different blends of two different CD-conjugated peptides onto our 100% PS-
PEO-Ada surface following the same conjugation protocol. As well as the commonly used RGD 
cell attachment sequence derived from Fibronectin, we also tested a Laminin-derived motif, 
IKVAV. As is expected, 100% PS-PEO-Ada surface exhibited the similar CD-IKVAV 
conjugation kinetics to that of CD-RGD (Figure 6). Determined by QCM, the measured mass 
and the calculated conjugation level of CD-IKVAV on 100% PS-PEO-Ada surface are 27.1 
ng/cm2 and 34% , respectively. This fact evidenced that the investigated surfaces had the similar 
CD-IKVAV conjugation level to that of CD-RGD (32%).  
Figure 6 here 
After 2 h of culture with hMSCs, all the surfaces conjugated with different ratios of RGD and 
IKVAV exhibited similar levels of cell adhesion to that of the TCP substrate, as determined by 
crystal violet staining (Figure 7). As described earlier, after 24 h of cell culture, hMSCs cultured 
on CD-RGD conjugated PS-PEO-Ada surfaces showed well spread morphologies and well-
organised actin with multiple stress fibres (Figure 4h). However, when we increased the amount 
of CD-IKVAV within the blends of CD-peptides on the PS-PEO-Ada surfaces, in the range from 
25 mol% to 75 mol %, an increase in the number of hMSCs displaying a round morphology was 
observed (Figure 8a-8c). The average cell spread area also decreased and the cytoskeletal 
architecture changed, with cells showing a switch from highly aligned stress-fibres spanning the 
length of the cell, to smaller, less well-organised fibres. When the hMSCs were cultured on a 
 19 
100% CD-IKVAV conjugated PS-PEO-Ada surface, the majority of cells displayed rounded 
shapes, with significantly decreased average cell spread area and poorly organized actin that was 
predominantly localized to the cell periphery (Figure 8d). Figure 8e shows the decreasing trend 
of average cell spread area depending on the amount of CD-RGD peptide in the blend. This 
ability to systematically vary morphologies and cell spread areas of stem cells by simply 
changing the ratios of CDs (modified with different adhesion peptides) added to the substrate 
prior to cell culture represents a truly enabling technology platform. 
Figure 7 and Figure 8 here 
CONCLUSIONS 
In this paper, we have demonstrated a facile approach to conjugate β-CD modified peptide 
sequences (CD-RGD and CD-IKVAV) onto self-assembled PS-PEO-Ada films through non-
covalent interactions between β-CDs and adamantane motifs. Upon simply blending different 
contents of PS-PEO-Ada with PS-PEO, the self-organized polymer films exhibited controllable 
differences in average lateral spacings of PEO domains, and thus permitted precisely controlled 
surface nano-presentation of peptide sequences. Depending on the density of surface bound CD-
RGD, hMSCs showed increased adhesion and variations in morphology, ranging from rounded 
to highly spread, with associated changes in cytoskeletal organization from a disorganized actin 
cytoskeleton to well-defined and highly aligned stress fibres. By simply mixing different 
amounts of CD-RGD and CD-IKVAV, PS-PEO-Ada films with tuned surface presentation of 
different peptides were also generated. The cell adhesion assays on these surfaces revealed that 
the morphologies of hMSCs can be effectively manipulated, from rounded cells with lower 
spread areas on IKVAV conjugated substrates, to well spread cells with significantly increased 
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spread area on RGD conjugated surface, yet the initial adhesion was similar in terms of cell 
number. Such differences in hMSC spreading and cytoskeletal organisation have been shown to 
influence the differentiation of hMSC populations and therefore suggest future potential for the 
surfaces described herein to help direct the fate of hMSCs in tissue engineering applications. It is 
worth noting that the facile 'lock-and-key' peptide conjugation technique presented in current 
work is also applicable to fabricate a wide range of peptide-conjugated biomaterials through the 
unique inclusion complexing interactions between cyclodextrins and specific moieties.   
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FIGURES.  
 
Figure 1. 1H NMR spectra of PS-PEO and PS-PEO-Ada (a), and N1s XPS spectra of PS-PEO, 
and PS-PEO-Ada films before (PS-PEO-Ada) and after conjugation with CD-RGD (PS-PEO-
Ada-RGD) and CD-IKVAV (PS-PEO-Ada-IKVAV) moieties (b).  
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Figure 2. AFM height images of polymer substrates obtained from self-assembly of (100%) PS-
PEO (a), and co-self-assembly of PS-PEO with 25% (b), 50% (c), 75% (d) of PS-PEO-Ada; the 
calculated average PEO domain size and inter-domain spacing of the resultant polymer films (e); 
AFM image of self-assembled (100%) PS-PEO-Ada (f). 
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Figure 3. QCM-D response curves, in terms of changes in frequency, during the non-covalent 
conjugation of CD-RGD to the self-assembled PS-PEO, PS-PEO-Ada, and their blend surfaces 
(a); water contact angle of 75% PS-PEO-Ada surface before and after being conjugated with CD-
RGD (b). 
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Figure 4. Adhesion of hMSCs to β-CD-RGD non-covalently conjugated polymer substrates 
obtained by the co-self-assembly of PS-PEO with different content of PS-PEO-Ada. Control is 
TCP (without β-CD-RGD). Error bars represent mean ± SD for n = 4, (*) p < 0.05, (**) p < 0.01. 
All the cells were cultured on the substrates at a density of 3,000 cells/cm2 in serum-free media 
for a period of 2 hours. 
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Figure 5. Fluorescent microscopy images of hMSCs on different polymer surfaces: PS-PEO 
alone (a); PS-PEO incubated in the presence of CD-RGD (b); CD-RGD conjugated polymer 
surfaces constructed by co-self-assembly of PS-PEO with 25 wt% (c), 50 wt% (d), and 75 wt% 
(e) of PS-PEO-Ada; 100% PS-PEO-Ada surface with (f) and without (g) CD-RGD conjugation; 
average cell area as function of surface content of PS-PEO-Ada (h). The scale bars in (a)-(g) are 
100 μm. Inset scales bars 20 μm. All the cells were cultured on the substrates at a density of 
3,000 cells/cm2  in serum-free media for a period of 24 hours. 
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Figure 6. QCM-D response curves, in terms of changes in frequency, during the non-covalent 
conjugation of CD-IKVAV to the self-assembled 100% PS-PEO-Ada surface.   
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Figure 7. Adhesion of hMSCs to self-assembled PS-PEO-Ada surfaces conjugated with different 
molar ratios of CD-RGD and CD-IKVAV, compared to control TCP. Error bars represent mean 
± SD for n = 4, p < 0.05. All the cells were cultured on the substrates at a density of 3,000 
cells/cm2  in serum-free media for a period of 2 hours. 
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Figure 8. Fluorescent microscopy images of hMSCs on self-assembled 100% PS-PEO-Ada 
surfaces conjugated with different molar ratios of CD-RGD and CD-IKVAV peptide sequences: 
75% (a), 50% (b), 25% (c), and 0% (d) of  RGD; the projected average cell area as a function of 
the molar ratio of RGD (e). The scale bars in (a)-(d) are 100 μm (in insets, 20 μm). All the cells 
were cultured on the substrates at a density of 3,000 cells/cm2  in serum-free media for a period 
of 24 hours. 
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SCHEMES.  
 
Scheme 1. Molecular structure of PS-PEO-Ada (a), schematic illustration of the cross section 
of the peptide conjugated self-assembled PS-PEO-Ada surfaces (b). 
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